Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma
Recruiting now · Phase 3
Conditions studied: Squamous Cell Cancer of Head and Neck (SCCHN)
In brief
The main objective of this trial was to determine the value of concurrent chemoradiotherapy for Intermediate-risk head and neck squamous cell carcinoma
Key facts
- Study ID
- NCT07125755
- Run by
- Sun Yat-sen University
- People needed
- 386
- Starts
- 2025-08-15
- Expected to finish
- 2031-08-15
- Last updated by the study team
- 2026-03-23
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- A. The pathological type is head and neck squamous cell carcinoma
- Stages
- B. Radical surgery has been performed, and there are intermediary-risk factors (pT3/pT4, pN2/pN3, positive lymph nodes in the cervical IV/V region of oral cancer, nerve invasion, and vascular invasion).
- C. No evidence of distant metastasis (M0).
- D. Functional status: Karnofsky scale (KPS) > 70.
- E. Normal bone marrow function:
- white blood cell count > 4×109/L
- hemoglobin > 120g/L in males, 110g/L in females
- platelet count > 100×109/L
- G. Normal liver function:
- alanine aminotransferase (ALT), aspartate aminotransferase (AST) < 1.5 times the upper limit of normal (ULN)
- alkaline phosphatase (ALP) < 2.5×ULN
- bilirubin < ULN.
- H. Normal renal function: creatinine clearance > 60 ml/min.
- I. Patients must be informed of the basic contents of this study and sign informed consent.
You may not qualify if…
- A. Age >70 years or <18 years.
- B. Treatment is palliative.
- C. Previous chemotherapy (except induction chemotherapy prior to surgery).
- D. Previous radiation therapy.
- E. Women who are pregnant or breastfeeding
- F. Previous history of malignant tumor.
- G. With other serious medical conditions that may pose a greater risk or affect compliance with the test. Examples include:
- unstable heart disease that requires treatment
- kidney disease
- chronic hepatitis
- poorly controlled diabetes (fasting blood glucose > 1.5×ULN)
- mental illness.
Where it is running
- Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China (enrolling)
- Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China (enrolling)
- Affiliated Hospital of Guilin Medical College — Guilin, Guangxi, China (enrolling)
- Hainan General Hospital — Sanya, Hainan, China (enrolling)
- Hunan Cancer Hospital — Changsha, Hunan, China (enrolling)
- Xiangya Hospital, Central South University — Changsha, Hunan, China (enrolling)
- Jiangsu Cancer Hospital — Nanjing, Jiangsu, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.